Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Potent new antitumor agents revealed by Takeda

Nov. 15, 1996

IND filed in Canada for Neovastat

Nov. 15, 1996

Eisai discloses antitumor compounds

Nov. 15, 1996

Antineoplastic tyrosine kinase inhibitors disclosed by Thomae

Nov. 15, 1996

Promising clinical trial results on Taxotere presented at ESMO meeting

Nov. 15, 1996

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

First alternative to 5-FU controls disease progression in colorectal cancer

Nov. 15, 1996

Gemzar introduced in Italy

Nov. 15, 1996

Phase II results with DaunoXome in non-Hodgkin's lymphoma

Nov. 15, 1996

Phase I tolerability and safety reported for Agouron's AG-331

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026